Imbalanced protease activity has long been recognized in the progression of disease states such as cancer and inflammation. Serpins, the largest family of endogenous protease inhibitors, target a wide variety of serine and cysteine proteases and play a role in a number of physiological and pathological states. The expression profiles of 20 serpins and 105 serine and cysteine proteases were determined across a panel of normal and diseased human tissues. In general, expression of serpins was highly restricted in both normal and diseased tissues, suggesting defined physiological roles for these protease inhibitors. A high correlation in expression for a particular serpin-protease pair in healthy tissues was often predictive of a biological interaction. The most striking finding was the dramatic change observed in the regulation of expression between proteases and their cognate inhibitors in diseased tissues. The loss of regulated serpin-protease matched expression may underlie the imbalanced protease activity observed in pathological states.
Proteases play critical roles in many normal processes such as development, coagulation, and immunity. Therefore, regulatory mechanisms must exist to ensure that homeostasis is maintained. In this regard, there are endogenous inhibitors for most of the known protease families [1] . A protease and its cognate inhibitor may normally be closely matched in site and amount of expression. An imbalance in expression patterns may arise as either a causative or responsive element in disease.
We have chosen to study the largest family of endogenous protease inhibitors, the serpins, which target a wide variety of serine and cysteine proteases [2, 3] . Over 1000 serpins have been identified across all species, including 37 human forms [4] . Their function is mediated by a unique suicide substrate mechanism, in which cleavage of an exposed substrate-like sequence (reactive site loop, RSL) causes a dramatic conformational change in the serpin, thereby trapping the protease in a covalently bound, inactive state [5] . The first known serpin, α1antitrypsin (SERPINA1), is a secreted glycoprotein that is found in high levels in the serum [6] . It is produced primarily in the liver, but also by a few inflammatory and epithelial cell types [7] . A primary site of action is the lung, where SERPINA1 inhibits human neutrophil elastase, preventing tissue damage. Hereditary loss of SERPINA1 has been implicated in chronic liver disease and emphysema, as well as an increased risk of liver and other cancers [6, 8] . Conversely, elevated plasma levels of the serpin squamous cell carcinoma antigens SCCA1 and 2 (SERPINB3 and SERPINB4) are an established marker for this disease [9, 10] . Although they interact in vitro with cathepsins S, L, and K, or cathepsin G and chymase, respectively, the biological roles of SERPINB3 and SERPINB4 remain unknown [11, 12] . Here we suggest that expression profiling correlation may aid in the identification of novel in vivo functions of serpins and potential target proteases.
We utilized real-time PCR (TaqMan PCR) to determine the expression profiles of 20 serpins and 105 serine and cysteine proteases across a panel of 58 samples from a collection of 13 cell lines and 31 normal and 14 diseased human tissues. In general, highly restricted expression of serpins was observed in normal and diseased tissues, suggesting defined physiological roles for these protease inhibitors. Furthermore, in specific cases, the expression correlations observed in lung, ovarian, breast, and prostate cancer tissues were altered compared to normal tissues.
Results

Protease and serpin selection criteria
The entire human genomic complement of proteases (greater than 500) and serpins (37) is relatively large [1, 13] . Criteria were therefore used to select a subset for transcription profiling. Factors included known disease link, known target or substrate, site of expression (tissue, intracellular or secreted), protein structure (fold, essential catalytic or inhibitory residues), and homology to proteins of known activity or disease relevance. Aspartyl and metalloproteases were removed from consideration, as serine (trypsin, subtilase) and cysteine proteases account for the majority of proteases known to interact with serpins. In this way, a total of 81 trypsin, 10 subtilase, and 14 cysteine proteases were selected for profiling (Supplemental Table 1 ).
Particular attention was paid to disease relevance and site of expression in the selection of serpins. This resulted in the selection of most of the intracellular ov-serpins (clade B) [2] . Although an effort was made to avoid secreted serpins, as site of action may not correlate well with site of expression, we did select a small number of secreted serpins (clades A, E, and I), based primarily on biochemical characterization and disease biology. Several novel, previously uncharacterized serpins were also selected. In total, 20 serpins (Table 1) were chosen such that the method could be validated with known interactions and that new serpin-protease pairs might be identified de novo.
Serpin expression profile
The expression profile of 20 serpins across 58 samples from a collection of 13 cells and 31 normal and 14 diseased human tissues is depicted in Fig. 1A . The normalized relative expression is represented by a light to dark color grid, which shows low to high levels of mRNA transcripts. For example, SERPINB1 and SERPINB8 are ubiquitously expressed, whereas SERPINI2 is expressed only in pancreas. In general, good agreement was found between the serpin mRNA expression patterns in this work and previously reported results (mRNA and/or protein). This would include serpins A1, A3, and A4 (liver, pancreas, and kidney) [7, 14, 15] ; A5 (pancreas, kidney, liver, and ovary) [16] ; B8 (digestive tract, lung, liver, pituitary, skin, and tonsil) [17] ; I1 (brain cortex, hypothalamus, pituitary, and spinal cord) [18] ; and I2 (pancreas) [19] . The most striking and unexpected finding is the restricted expression of most serpins. The majority of the serpins are expressed at "high" levels in four or fewer, often related, tissues in our panel ( Fig. 1A) . This supports the hypothesis that serpin expression is highly regulated and that imbalanced expression may lead to pathological states. The tight regulation of serpin expression is represented in Figs. 1B and 1C. SERPINA11 (Fig. 1B) , a previously unknown patent sequence, exhibits a restricted expression pattern typical of many serpins: very high expression in normal liver, with >30fold less expression in normal breast, prostate BPH (benign prostate hyperplasia), and breast tumor. SERPINB4 (SCCA2) (Fig. 1C) shows dramatically elevated levels of expression in lung and prostate tumor tissues versus the corresponding normal tissues. This finding is confirmatory of many studies in which SERPINB4 has been identified as a marker for lung and other types of cancer [20, 21] . Low levels of expression were also seen in normal tonsil, normal pituitary, hemangioma tumor, colon IBD (inflammatory bowel disease), and breast tumor.
Expression correlation in normal tissues
One of the major challenges is to elucidate the functions of serpins and proteases whose functions are unknown. Mining expression profiles is one method to uncover gene function. It is well reported in the literature that genes that encode proteins that participate in the same pathway or are part of the same protein complex are often coregulated [22] . Clusters of genes with related functions often exhibit similar expression patterns across a diverse collection of samples. Tissue-specific gene expression can be used to predict tissue-specific function. Therefore, we explored the relationship between serpins and proteases based on the coregulation of expression in normal human tissues.
We analyzed the expression correlation of 20 serpins (Table  1 ) and 105 proteases (Supplemental Table 1 ) across a panel of 25 normal human tissues (Supplemental Table 2 ). A heat map displaying the results of this analysis is shown in Fig. 2A and the correlation values are listed in Supplemental Table 1 . Only serpin-protease pairs with a correlation value >0.7 were investigated further (see below). This cutoff value eliminated most, if not all, spurious/weak correlations. We also observed that several serpins shared distinct banding patterns of high correlation ( Fig. 2A ). This primarily reflects predominant expression in liver of serpins A1, A3, A4, and A11 with proteases trypsin, KAL, IF, HTRA4, FA10, FA12, FA7, and Eos, or in tonsil of serpins B7, B10, B11, and B13 with proteases KLK10, KLK12, and KLK13.
We used this information to match gene expression patterns of proteases with their putative inhibitors as a starting point to understand functional relationships and roles played by serpinprotease pairs under physiological conditions. To exemplify our findings, the data obtained from two serpin-protease pairs are depicted here. SERPINB8 is coexpressed with the subtilasetype protease furin ( Fig. 2B ) and SERPINE3 with the subtilase proprotein convertase, type 4 (PCSK4) (Fig. 2C ).
SERPINB8 is broadly expressed across the panel, most notably in liver, skeletal muscle, artery, heart, and smooth muscle cell (SMC) coronary tissues. Furin expression matches that of SERPINB8 in most cases, with a correlation of 0.8. SERPINB8 inhibits furin in vitro with an overall K i of 54 pM [23] . Although SERPINB8 is known to inhibit several other trypsin-and subtilase-type proteases in vitro, it is notable that the RSL contains two putative cleavage sites, RNSR↓ and RCSR↓, which conform to the minimal furin consensus sequence RXXR↓ [24] [25] [26] . Collectively, these data suggest that SER-PINB8 may play a role in the regulation of furin activity in vivo.
The expression profile of SERPINE3 ( Fig. 2C ) is more restricted than that of SERPINB8, with highest levels found in neural tissues, such as brain, pituitary, and spinal cord ( Fig. 1A) . PCSK4, a member of the proprotein convertase family, correlates in expression with SERPINE3, with an acceptable range of correlation among most of the normal tissues. The correlation is >0.70 in neural tissues such as brain, spinal cord, and pituitary gland ( Fig. 2C and data not shown). Although the primary site of PCSK4 expression has been reported to be in the testes (not included in this study), our results show significant expression in many other tissues such as neural, erythroid, kidney, and pancreas [27] . While the target of SERPINE3 is unknown, PCSK4 is a highly specific enzyme, preferring a consensus sequence of KPXR↓XP [28] . A similar sequence is found in the RSL of SERPINE3, KRSR↓IP. These data suggest SERPINE3 as the cognate inhibitor of PCSK4 in vivo.
Expression correlation in oncology samples
Increased protease activity has been implicated in the genesis of many tumors and metastases [29, 30] . We postulate that increased protease activity may be due to the loss of matched expression between a protease and its paired serpin. To test this hypothesis we analyzed the expression correlation of serpinprotease pairs across a panel of five different normal and tumor tissues (breast, lung, colon, ovary, and prostate) ( Fig. 3 ). We assumed that at least four scenarios are likely to occur during tumorigenesis and they are described below:
(1) Expression of serpin is elevated to compensate increased protease expression in the diseased tissue. (2) Protease expression increases, while that of the serpin remains unchanged, leading to imbalanced protease activity. (3) Serpin expression drops, while that of the protease remains the same or increases, leading to imbalanced protease activity. (4) Serpin expression increases, while that of the protease remains the same or decreases.
We present examples of the different scenarios as illustrated by serpin-protease pairs of high expression correlation in normal tissues. Expression of SERPINB8 and furin ( Fig. 3A ) remains balanced in normal and tumor tissues from breast, colon, lung, and ovary. Although two-to threefold increases in furin levels are observed in colon, lung, and prostate tumors, the level of expression of SERPINB8 increases proportionally. In this example, serpin expression accompanies the increased levels of protease in tumor samples. The elevated expression of furin in lung, head and neck, and prostate cancer has been previously reported [29, 31, 32] . This may allow for the increased secretion of growth factors and matrix metalloproteases, which in turn leads to increased tumorigenesis and invasiveness. However, if SERPINB8 expression levels rise, as observed here, to compensate for elevated furin expression levels, this effect would be ameliorated.
Expression of SERPINA5 and the trypsin-type protease transmembrane protease, serine 3 (TMPRSS3) ( Fig. 3B ), is matched in normal breast, colon, ovary, and prostate with low levels of unmatched TMPRSS3 expression in the normal lung. TMPRSS3 is elevated significantly, as much as 10-to 20-fold, in breast and ovary tumors, while SERPINA5 expression remains unchanged. Slight increases in TMPRSS3 expression were also seen in colon and prostate. TMPRSS3 has been previously identified as a marker in pancreatic and ovarian cancer [33, 34] . It is expressed on the surface of cells and appears to possess cleavage specificity after basic amino acids, such as Arg and Lys [34] . SERPINA5 (protein C inhibitor) is a known inhibitor of thrombin and several other coagulation proteases, all of which possess a preference for basic amino acids [35, 36] .
Matched or slight overexpression of SERPINB1 relative to the subtilase-type protease tripeptidyl peptidase 2 (TPP2) is seen in normal tissues (Fig. 3C ). The elevated expression of TPP2 in colon tumor (∼10-fold) is met by increased expression of SERPINB1. The normal role of TTP2 is the processing of peptides for eventual display in the MHC class I pathway. TPP2 is found as a multimer of 135-kDa subunits and primarily functions as a relatively nonspecific tripeptidyl aminopeptidase, though endoproteolytic cleavage can occur [37] [38] [39] . SERPINB1 is among the most broadly expressed serpins, suggesting a general role. It inhibits a wide variety of elastase-and chymotrypsin-like serine proteases by utilizing two separate sites on its RSL [40] [41] [42] . One function of SERPINB1 may be to protect neutrophils from elastase and other serine proteases that are highly expressed in these cells. Both SERPINB1 and TPP2 are cytosolic proteins and may interact. As the activity and specificity of TPP2 are not currently well understood, the potential interaction of SERPINB1 and TPP2 merits further investigation.
Low, but matched, expression of SERPINA1 and the trypsintype protease hyaluronan binding protein 2 (HABP2) is observed in normal tissues (Fig. 3D ). Expression of HABP2 in colon tumor is elevated 18-fold versus colon normal, whereas the levels of SERPINA1 remain unchanged. (Small changes in lung tumor expression versus lung normal are not significant for either HABP2 or SERPINA1.) HABP2 is a multidomain serine protease found primarily in plasma [43] [44] [45] . It has been identified in other studies as a significant marker for lung adenocarcinoma [46] . SERPINA1 is associated with lung disease, and the coexpression with HABP2 suggests these two proteins interact in vivo. However, the fact that both the serpin and the protease are also found in plasma may complicate the analysis.
Discussion
Serpin expression is highly tissue specific in both normal and diseased tissues Strikingly, the majority of the serpins examined in this study exhibited tightly regulated expression across a wide variety of tissues, suggesting physiological roles that may be much more precise than simply the general regulation of proteolysis. This is Table 2 ). Each serpin was matched against 105 proteases and correlation values >0.7 were further investigated (Supplemental Table 1 ). Several distinct banding patterns of high correlation reflect similar tissue-specific serpin expression in liver, pancreas, and kidney (SERPINA1, A3, and A4) or tonsil (SERPINB7, 10, 11, and 13). (B) SERPINB8 with subtilase/furin. Expression profile of SERPINB8 with furin (GenBank X17094) shows correlation value of 0.70 compared across 25 normal tissues (Supplemental Table 2 ). SERPINB8 is broadly expressed across the tissue panel, most notably in liver, skeletal muscle, artery, heart, and SMC, coronary. Furin expression matches that of SERPINB8 in most cases, with a correlation of 0.8. (C) SERPINE3 with subtilase/PCSK4 (proprotein convertase subtilisin/kexin type 4). Expression profile of SERPINE3 with PCSK4 (GenBank BC036354) shows correlation value of >0.7 compared across neural tissues only (exception for this pair) and has acceptable correlation compared with the rest of the 25 different normal tissues (Supplemental Table 2 ). The expression profile of SERPINE3 is more restricted than that of SERPINB8, with highest levels found in neural tissues, such as brain, pituitary, and spinal cord. PCSK4, a member of the proprotein convertase family, correlates in expression with SERPINE3, with an overall value of 0.9.
amply illustrated by such serpins as I1 (neural tissue), I2 (pancreas), or B4 (lung cancer). This is consistent with the numerous tissue-specific functions involving serpins, including blood coagulation and fibrinolysis, spermatogenesis, neural function, and prohormone conversion [2, 3] . Also of interest is that the expression patterns observed in this study often appear clade-specific. Most clade A serpins are expressed in the major secretory organs such as liver, pancreas, and kidney. Other clades, such as clade B, appear more broadly expressed, but definitive analysis must await further profiling of the remaining human serpins. That serpin function might follow phylogenetic classification would greatly aid in the study of previously uncharacterized serpins and the identification of cognate proteases.
Correlation analysis of normal tissue expression identified both existing and plausible serpin-protease pairs
Our correlation method clearly identified an existing interaction in one example (SERPINB8-furin) [23] and suggested a novel interaction (SERPINE3-PCSK4) in another. Given the small subset of proteases and inhibitors that was examined in this study, this would indicate that expression correlation is a useful tool in addition to standard biochemical and cell biological methods. The technique does appear to be more robust with subtilase-versus trypsin-type serine proteases and cysteine proteases. This may reflect differing biological roles and general location of each protease class or the particular mechanism of interaction of each serpin with its protease target. As a general rule, subtilase-type proteases are intracellular, while trypsin types are secreted. This makes precise localization more difficult for the trypsin-type proteases and may complicate expression correlation efforts in some cases.
Of note is the fact that multiple serpins and proteases can be expressed in the same tissue, such as liver, or that one serpin may associate with multiple proteases [2, 3] , making it difficult to assign partners on the basis of correlation alone. Therefore, we promote the use of correlation data as a first step to understanding expression patterns and to narrow down possible serpin-protease pairings. However, we recognize that correlation data alone are insufficient for thorough evaluation of serpin-protease pairs and need to be combined with other biological and biochemical information to understand the full impact of serpin-protease pairings on tissue homeostasis. In addition, as discussed above, when serpin and/or protease is secreted, this approach may not be ideal, as site of expression may not correlate with site of action in these cases.
Serpin and protease expression varies dramatically in cancer, resulting in an imbalance that may play a role in disease progression or response
As the proteases examined in this study were often chosen on the basis of disease relevance, expression correlation may identify a serpin as an important regulator of potentially pathogenic activity in normal tissues. Such knowledge may be critical in understanding the role of relatively obscure proteases such as TMPRSS3 and HABP2 in cancer. We were intrigued by the large changes in protease expression that were observed. Ten-fold or greater increase was not uncommon. That the serpin expression sometimes compensated was remarkable. These serpins may represent a legitimate attempt by the body to counterbalance overproduction of proteases. Thus recognized, they may provide new insight into the mechanism and treatment of the disease. Computational tools such as presented here can provide useful information in this regard.
For example, our data show that TMPRSS3 expression increases 10-to 20-fold in breast and ovary tumors compared to normal breast and ovary tissues. The expression level of its potential inhibitor, SERPINB5, identified in this study (Fig. 3B ) remains unchanged, leading to the hypothesis that dysregulation of TMPRSS3 activity may trigger certain events that are necessary for either the initiation or the maintenance of oncogenesis in these tumor types. This hypothesis can be addressed by the use of siRNA to knockdown expression of TMPRSS3 and/or SERPINB5 in these tumors to establish relevance to disease initiation and/or progression.
Relationship between gene function and transcriptional coexpression
Correlations among the transcript levels in normal tissues were examined to illuminate the relationship between proteases and serpins. The assumption is that alterations in gene expression will manifest themselves at the level of biological pathways or coregulated gene sets, rather than at the level of individual genes [47] . In this approach, genes that have similar expression patterns across a set of normal tissue samples are hypothesized to have a functional relationship, such as physical interaction between the encoded proteins, though coexpression of transcripts does not necessarily imply a causal relationship among proteins [48] . Gene-to-gene relationships based on transcript levels are purely subjective and need further validation by functional relationship, e.g., biological and biochemical assays. In this paper we have made an attempt to bring certain serpins and proteases together based on transcript-level correlation in various normal tissues. Several pairings have been identified, laying the foundation for future experiments.
Materials and methods
Protease and serpin selection
A variety of bioinformatic methods were used over the course of this project, due to the evolving nature of human sequence databases during the execution of this project. Expressed sequence tag (EST) databases were either searched directly or clustered with d2 [49] . Genomic sequences were scanned with FGENESH [50] or GenScan [51] to generate potential transcripts. These datasets were then searched using TBLASTN with a defined set of protein probes or translated HMMER searches using a Paracel GeneMatcher and appropriate models from PFAM [52] . Protein probes for BLAST [53] were first examined for repetitive regions or domains not of interest to the searches and these regions masked out prior to conducting the search. Phrap [54] and BLASTN were used to identify overlapping ESTs or genomic predictions that overlapped each other or EST hits. Using the clustered sequence results, GenBank accession numbers, gene symbols, and annotations were assigned and catalogued.
Tissue and cell samples
Human biological materials were collected from two major sources: fee-forservice tissue providers and academic collaborators. The tissue samples were collected and frozen by liquid nitrogen within 3 h or less of surgery. In all cases, informed consent granting use of the tissue for research purposes was obtained from the patients prior to sample collection. Personal identifiers were stripped from the samples and the samples were made anonymous prior to shipment to Millennium's central biorepository, the Molecular and Biologic Resource Center. All tissue samples were evaluated by a pathologist by hematoxylin and eosin stain and stored at −80°C before being processed into cDNA. We generated a panel of 58 different samples that were collected from 31 normal tissues, 14 diseased tissues, and 13 cell types. To account for biological variability, the clinical tissue samples consist of pooled cDNA samples containing representative specimens from three different human donors, with both genders represented, whenever possible. Oncology pools often contain representative types of different common tumors of that organ, so as to conduct as wide a survey as possible. Tumor sample pools are identified only by the organ of origin.
Tissue selection criteria for correlation analysis
Tissues were chosen for transcript analysis to evaluate oncology and inflammation paradigms. Normal tissues represent all critical organs in the human body except some of the neural tissues such as brain due to generally high levels of transcriptional activity. Diseased tissues are more relevant to represent oncology and inflammation-related diseases, e.g., tumors, IBD, and COPD.
RNA extraction
Total RNA extraction was carried out using RNA-STAT (Tel-Test, Inc., TX, USA) according to the manufacturer's protocol (RNA Stat 60 User Bulletin). The purity and integrity of the RNA were assessed on the Agilent 2100 bioanalyzer with the RNA 6000 Nano Labchip reagent set (Agilent Technologies, CA, USA). The RNA was quantified spectrophotometrically and treated with DNase (Ambion, TX, USA) for 30 min at 37°C. DNase-treated RNA was extracted from the samples and stored at −80°C.
cDNA generation
First-strand cDNA synthesis was performed with the ABI reverse transcription system (Applied Biosystems, CA, USA) according to the manufacturer's protocol. The cDNA quality was assessed by generating expression profiles of 18S ribosomal and β2-microglobulin (B2M) genes with real-time PCR (ABI 7700; Applied Biosystems). cDNA samples were stored at −20°C.
Primers and TaqMan probe design
mRNA sequences for all proteases and serpins were derived from GenBank (for accession numbers, see Table 1 and Supplemental Table 1 ) and primers and TaqMan probes were designed with Primer Express software, version 2.0 (Applied Biosystems). We targeted the design at the 3′end of the open reading frame of the gene. All primers were obtained from MWG Biotech (NC, USA) and 6-carboxyfluorescein-labeled probes were obtained from Applied Biosystems. For the normalization of our results, we used VIC-labeled B2M reagents from Applied Biosystems. Each of the probes was quenched by 6carboxytetramethylrhodamine.
Primer and probe quality control
Each primer and probe pair was tested for PCR efficiency in a synthetic template system. Primer and probe pairs were thoroughly tested by 7 logs of dilution with synthetic template and also on human control cDNA. Reagents that passed the criteria were validated for use in expression profiling experiments. All of the protease and protease inhibitor assays provided the best result with the highest primer and probe concentration (900 nM primers and 250 nM probe), multiplexed with a housekeeping gene at primer limited concentration (200 nM primers and 200 nM probe).
TaqMan real-time PCR
TaqMan PCR assays were performed on an ABI Prism 7700 sequence detection system (Applied Biosystems). Multiplexed assay was performed with protease or serpin reagent sets with the human B2M gene as an endogenous control. All quantitative assays designed using ABI guidelines were run using the same universal thermal cycling parameters. Cycling parameters were run at 50°C for 2 min, 95°C for 10 min to activate the DNA polymerase and then 40 cycles of 95°C for 15 s, 60°C for 1 min.
Data analysis
Data were analyzed using SDS 1.7 (Applied Biosystems) software. The first step was to generate an amplification plot for every sample, which showed ΔR n on the y axis (where R n is the fluorescence emission intensity of the reporter dye normalized to a passive reference) against the cycle number on the x axis. From each amplification plot, a threshold cycle (C t ) value was calculated, which was defined as the cycle at which a statistically significant increase in ΔR n was first detected, and was displayed in the graph as the intercept point of the amplification plot and threshold. The obtained C t values were exported to an Excel spreadsheet for further analysis.
Relative expression calculation
Relative quantitation is used to compare the changes in steady-state mRNA levels of two or more genes to each other, with one of them acting as an endogenous control [55] . Normalization of target gene expression levels was performed to compensate intra-and interkinetic RT-PCR variations. Data normalization was carried out against an endogenous unregulated gene transcript. Based on the exponential amplification of the target gene, as well as the normalizer, the amount of amplified molecules at the threshold cycle was given by Relative Expression ¼ 2 −∂∂CT AAC T ¼ AC T;q À AC T;cb This equation is based on the precondition that the efficiencies of target and reference amplification are approximately equal and ∂C T,q is the difference between target and endogenous reference control and ∂C T,cb is the calibrator sample (no template control).
Calculation of correlation values
The Spotfire functional genomics version 7.3 software (Spotfire, Inc., MA, USA) tool was used to analyze the data generated from proteases and serpins on the same subset of 25 normal tissue samples: adipose, adrenal gland, artery, bladder, breast, colon, dorsal root ganglion, heart, kidney, liver, lung, lymph node, ovary, nerve, pancreas, pituitary gland, prostate, spinal cord, skeletal muscle, small intestine, spleen, stomach, thymus, tonsil, and vein (Supplemental Table 2 ). The Spotfire Profile search tool was utilized to search for similar expression profiles between two genes, serpin and protease, based on the Pearson momentum correlation algorithm. Values of the correlation coefficient r range from +1 to −1, where +1 indicates highest similarity, while a completely opposite profile would give a −1 r value. Expression profiles with identical shape had higher correlation.
The gene expression profiles of the 25 normal tissues listed above were used to search for similarity between serpins and proteases. If the correlation value of two genes was greater than 0.7, we arbitrarily defined the expression of those two genes as closely correlated. For each serpin, a set of proteases was selected according to their correlation values and the best matched proteases were investigated further by evaluating the expression profile in normal and diseased tissues.
